Suzetrigine for Opioid-Free Recovery After Cesarean Delivery (NCT07534709)
Suzetrigine Versus Placebo for Opioid-Free Recovery After Cesarean Delivery: A Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to determine whether suzetrigine increases the proportion of patients who remain completely opioid-free from completion of surgery through 72 hours after cesarean delivery. The main question it aims to answer is: Does adjunctive suzetrigine, when added to a standardized multimodal postoperative analgesic regimen, increase the proportion of patients who remain opioid-free during the first 72 hours after cesarean delivery? Researchers will compare suzetrigine to a placebo (a look-alike substance that contains no drug) to evaluate this outcome. Participants will: * Receive either suzetrigine or placebo after cesarean delivery * Receive standard postoperative pain management, including acetaminophen, nonsteroidal anti-inflammatory drugs, and neuraxial morphine * Have opioid medications available as needed for breakthrough pain * Be followed during hospitalization and after discharge to assess pain, recovery, and medication use
Who can join: Review the eligibility criteria below.
Location: University of Texas at Austin Dell Medical School, Department of Women's Health — Austin, Texas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Texas at Austin Dell Medical School, Department of Women's Health — Austin, Texas
📞 Contact the Study Coordinator
Phone: (512) 771-0773
Email: calvertchase@utexas.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cesarean Delivery
- IC-CS Risk: Patient Outcomes — Ann Arbor, Michigan
- Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery — New York, New York
- BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP) — New York, New York
- Duration of Urinary Catheterization Following Cesarean Deliveries Under Neuraxial Anesthesia — Vancouver, British Columbia
- Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies — Philadelphia, Pennsylvania
Explore by condition: All Cesarean Delivery clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.